Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04972916 · ClinicalTrials.gov registry record · NA

Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients

A NA study of Tobacco Use, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04972916 is a NA study of Tobacco Use that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 12 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04972916, a NA study of Tobacco Use, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility and preliminary efficacy of patient navigation to promote linkage to smoking cessation treatments in cancer patients.

Conditions Studied

Interventions

  • OTHER Patient navigation-based tobacco harm reduction intervention

Study Locations (1)

Pennsylvania

  • Penn State Cancer Institute - Hershey

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-06-15
Est. Completion 2021-12-31
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04972916

The ClinicalTrials.gov registry entry for NCT04972916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (97% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Patient navigation-based tobacco harm reduction intervention is the first listed.

NCT04972916 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04972916 about?

NCT04972916 is a clinical study titled "Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients". The purpose of this study is to examine the feasibility and preliminary efficacy of patient navigation to promote linkage to smoking cessation treatments in cancer patients.

What is the current status of trial NCT04972916?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-06-15. Estimated completion is 2021-12-31.

What conditions does trial NCT04972916 study?

This clinical trial studies the following conditions: Tobacco Use.

What interventions are being tested in trial NCT04972916?

The interventions under investigation include: Patient navigation-based tobacco harm reduction intervention (OTHER).

Who is sponsoring clinical trial NCT04972916?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04972916 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.